{"result": {"id": "4d9e7420-72dc-4035-92c6-079ce8f74b3b", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "SPIRONOLACTONE and FINERENONE are both mineralocorticoid receptor antagonists that have been studied for the treatment of hypertension. While they share a similar mechanism of action, FINERENONE demonstrates a better safety profile in terms of hyperkalemia risk compared to SPIRONOLACTONE. This distinction makes FINERENONE a potentially preferable option in clinical settings where hyperkalemia is a concern. Both drugs remain important therapeutic agents within their class, with their use tailored to patient-specific factors.", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751559767, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 103, "prompt_tokens": 170, "total_tokens": 273, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 64}, "prompt_cache_hit_tokens": 64, "prompt_cache_miss_tokens": 106}}, "input": {"messages": [{"content": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or two entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we have the full context.\n\n#######\n-Data-\nEntities: [\"SPIRONOLACTONE\", \"FINERENONE\"]\nDescription List: [\"Both are mineralocorticoid receptor antagonists studied for hypertension treatment\", \"Finerenone offers better safety in hyperkalemia compared to spironolactone.\"]\n#######\nOutput:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 500, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_summarize_06fa752a569464152930bedbdd7a49ed309feddfff2c5f996a082892dbb38595_v2"}